|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coleman RE, Gregory W, Marshall H, Wilson
C and Holen I: The metastatic microenvironment of breast cancer:
Clinical implications. Breast. 22(Suppl 2): S50–S56. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sleeman JP, Nazarenko I and Thiele W: Do
all roads lead to Rome? Routes to metastasis development. Int J
Cancer. 128:2511–2526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta GP, Minn AJ, Kang Y, Siegel PM,
Serganova I, Cordón-Cardo C, Olshen AB, Gerald WL and Massagué J:
Identifying site-specific metastasis genes and functions. Cold
Spring Harb Symp Quant Biol. 70:149–158. 2005. View Article : Google Scholar
|
|
7
|
Klein CA: Parallel progression of primary
tumours and metastases. Nat Rev Cancer. 9:302–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar
|
|
10
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang H, Zhou P, Huang H, Chen D, Ma N, Cui
QC, Shen S, Dong W, Zhang X, Lian W, et al: Shikonin exerts
antitumor activity via proteasome inhibition and cell death
induction in vitro and in vivo. Int J Cancer. 124:2450–2459. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv
X and Chen F: Shikonin inhibits prostate cancer cells metastasis by
reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and
ROS/ERK1/2 pathways. Int Immunopharmacol. 21:447–455. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yeh CC, Kuo HM, Li TM, Lin JP, Yu FS, Lu
HF, Chung JG and Yang JS: Shikonin-induced apoptosis involves
caspase-3 activity in a human bladder cancer cell line (T24). In
Vivo. 21:1011–1019. 2007.
|
|
15
|
Zhang FL, Wang P, Liu YH, Liu LB, Liu XB,
Li Z and Xue YX: Topoisomerase I inhibitors, shikonin and
topotecan, inhibit growth and induce apoptosis of glioma cells and
glioma stem cells. PLoS One. 8:e818152013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujii N, Yamashita Y, Arima Y, Nagashima M
and Nakano H: Induction of topoisomerase II-mediated DNA cleavage
by the plant naphthoquinones plumbagin and shikonin. Antimicrob
Agents Chemother. 36:2589–2594. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jang SY, Lee JK, Jang EH, Jeong SY and Kim
JH: Shikonin blocks migration and invasion of human breast cancer
cells through inhibition of matrix metalloproteinase-9 activation.
Oncol Rep. 31:2827–2833. 2014.PubMed/NCBI
|
|
18
|
Wu K and Bonavida B: The activated
NF-kappaB-Snail-RKIP circuitry in cancer regulates both the
metastatic cascade and resistance to apoptosis by cytotoxic drugs.
Crit Rev Immunol. 29:241–254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mulholland DJ, Kobayashi N, Ruscetti M,
Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK
activation cooperate to promote EMT and metastasis initiated from
prostate cancer stem/progenitor cells. Cancer Res. 72:1878–1889.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J,
Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, et al: Transforming
growth factor-β1 promotes lung adenocarcinoma invasion and
metastasis by epithelial-to-mesenchymal transition. Mol Cell
Biochem. 355:309–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gara RK, Srivastava VK, Duggal S, Bagga
JK, Bhatt M, Sanyal S and Mishra DP: Shikonin selectively induces
apoptosis in human prostate cancer cells through the endoplasmic
reticulum stress and mitochondrial apoptotic pathway. J Biomed Sci.
22:262015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lombaerts M, van Wezel T, Philippo K,
Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de
Water B, Cornelisse CJ, et al: E-cadherin transcriptional
down-regulation by promoter methylation but not mutation is related
to epithelial-to-mesenchymal transition in breast cancer cell
lines. Br J Cancer. 94:661–671. 2006.PubMed/NCBI
|
|
28
|
Nguyen PT, Kudo Y, Yoshida M, Kamata N,
Ogawa I and Takata T: N-cadherin expression is involved in
malignant behavior of head and neck cancer in relation to
epithelial-mesenchymal transition. Histol Histopathol. 26:147–156.
2011.
|
|
29
|
Araki K, Shimura T, Suzuki H, Tsutsumi S,
Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin
switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ennen M, Klotz R, Touche N, Pinel S,
Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC,
Ledrappier S, et al: DDB2: A novel regulator of NF-κB and breast
tumor invasion. Cancer Res. 73:5040–5052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar
|
|
32
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
